Breaking News, Collaborations & Alliances

Champions Oncology Enters Collaboration with AstraZeneca

To develop unique cohorts of patient-derived xenograft (PDX) models

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Champions Oncology has entered a collaboration with AstraZeneca to develop novel cohorts of PDX models. These models will be used in AstraZeneca’s oncology R&D programs in breast and lung cancer, in addition to being added to Champions’ existing TumorGraft bank for translational oncology research for academic and industry customers. Champions’ global network of collaborating sites will be leveraged to support this multi-year initiative. These novel models will expand Champions’ bank of es...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters